Development of resistance to zidovudine in HIV strains isolated from CD4+ lymphocytes and plasma during therapy
- 15 June 1992
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 18 (3-4) , 303-316
- https://doi.org/10.1016/0166-3542(92)90063-b
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Double blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group.BMJ, 1992
- Isolation of HIV from cultures of purified CD4+ lymphocytesJournal of Virological Methods, 1991
- Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapyThe Lancet, 1990
- Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assayAntimicrobial Agents and Chemotherapy, 1990
- Decreased In Vitro Susceptibility to Zidovudine of HIV Isolates Obtained from Patients with AIDSThe Journal of Infectious Diseases, 1990
- Isolation of HIV using T-lymphocyte ‘panning’: methodological aspectsJournal of Virological Methods, 1989
- HIV with Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged TherapyScience, 1989
- EFFECTS OF ZIDOVUDINE IN 365 CONSECUTIVE PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1988
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- DETECTION OF HIV ANTIGENS IN ELUATES FROM WHOLE BLOOD COLLECTED ON FILTERPAPERThe Lancet, 1987